[{"arm_notes": "", "treatment_id": null, "treatment_name": "10 micrograms (0.1 mL) of tozinameran will be administered intradermally to the deltoid area with a sterile 30G inch needle.;30 micrograms (0.3 mL) of tozinameran will be administered intramuscularly to the deltoid area of the non-dominant arm with a sterile 25G needle.;Experimental Biological/Vaccine;Active Comparator Biological/Vaccine;fractionated-dose intradermal tozinameran;standard intramuscular tozinameran", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "intradermal", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "intramuscular", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]